Virax Biolabs Group Limited (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

0.1740

-0.0240 (-12.12%)

At close: Apr 2, 2026, 4:00 PM EDT

0.1605

-0.0135 (-7.76%)

After-hours: Apr 2, 2026, 7:59 PM EDT

Virax Biolabs Group Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	3.35	4.23	3.59	9.35	0.02	0.02
Cash & Short-Term Investments	3.35	4.23	3.59	9.35	0.02	0.02
Cash Growth	-54.08%	17.82%	-61.62%	42888.32%	23.47%	-22.06%
Accounts Receivable	0	-	-	-	-	0
Other Receivables	0.17	0.03	0.22	-	-	-
Total Trade Receivables	0.18	0.03	0.22	-	-	0
Inventory	0.05	0.09	0.06	-	0.02	0.02
Other Current Assets	0.57	0.54	0.51	0.28	0.01	-
Total Current Assets	4.15	4.89	4.38	9.63	0.05	0.04
Net Property, Plant & Equipment	1.57	1.53	1.1	-	-	-
Other Intangible Assets	-	-	-	0.18	-	-
Total Assets	5.72	6.43	5.48	9.81	0.05	0.04
Accounts Payable	0.1	0.59	0.12	0.72	1.24	0.87
Short-Term Debt	0.2	0.03	-	0.15	-	-
Current Portion of Leases	0.07	0.05	0.05	-	-	-
Unearned Revenue	-	-	-	0.04	-	-
Other Current Liabilities	-	-	-	-	0	0
Total Current Liabilities	0.37	0.67	0.17	0.91	1.25	0.87
Long-Term Leases	0.28	0.29	0.18	-	-	-
Total Long-Term Liabilities	0.28	0.29	0.18	-	-	-
Total Liabilities	0.64	0.96	0.35	0.91	1.25	0.87
Common Stock	0.01	0	0	0	0	0
Treasury Stock	-	-	-	-	-	-0.05
Additional Paid-in Capital	32.29	30.17	23.89	20.92	5.36	4.03
Accumulated Other Comprehensive Income	-0.06	0.11	0	-0	-0	-0
Retained Earnings	-26.93	-24.59	-18.53	-11.79	-6.34	-4.63
Total Common Shareholders' Equity	5.31	5.7	5.37	9.13	-0.97	-0.65
Minority Interest	-0.24	-0.23	-0.23	-0.22	-0.22	-0.18
Shareholders' Equity	5.07	5.46	5.14	8.9	-1.2	-0.83
Total Liabilities & Equity	5.72	6.43	5.48	9.81	0.05	0.04
Total Debt	0.54	0.38	0.22	0.15	0	0
Net Cash (Debt)	2.81	3.85	3.36	9.21	0.02	0.02
Net Cash Growth	-27.12%	14.47%	-63.45%	42216.09%	23.47%	-22.06%
Net Cash Per Share	0.62	1.03	1.68	8.66	0.02	0.11
Book Value	5.31	5.7	5.37	9.13	-0.97	-0.65
Book Value Per Share	1.16	1.53	2.67	8.59	-1.02	-4.11
Tangible Book Value	5.31	5.7	5.37	8.95	-0.97	-0.65
Tangible Book Value Per Share	1.16	1.53	2.67	8.42	-1.02	-4.11

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q